暂无推荐供应商。我要出现这里
化源商城直购
[1]. Codarri Deak L, et al. Beyond checkpoint inhibition: PD-1 cis-targeting of an IL-2Rβγ-biased interleukin-2 variant as a novel approach to build on checkpoint inhibition. Oncoimmunology. 2023 Mar 30;12(1):2197360.